Neutrophils: Heterogeneity, Biology, Diseases, and Therapeutic Strategies
- 1West China Hospital Sichuan University
Abstract
Neutrophils are the most abundant circulating leukocytes and are essential components of innate immunity, contributing to host defense, inflammation, tissue remodeling, and disease progression. Increasing evidence has revealed substantial neutrophil heterogeneity and functional plasticity, which enable distinct neutrophil populations to exert protective or pathogenic effects depending on the tissue and disease context. These properties have attracted growing interest in neutrophils as therapeutic targets and as vehicles for targeted drug delivery. This review summarizes the biological characteristics and functional heterogeneity of neutrophils, with particular emphasis on their recruitment, phagocytosis, oxidative responses, extracellular trap formation, and interactions with the tissue microenvironment. We further discuss the diverse roles of neutrophils in cancer, inflammatory diseases, infectious diseases, and other pathological conditions, highlighting their context‐dependent functions. Building on these insights, we review current and emerging therapeutic strategies, ranging from broad neutrophil modulation to precision targeting and neutrophil‐based drug delivery. Living neutrophil carriers, neutrophil membrane‐coated nanoparticles, and neutrophil‐derived vesicles are comparatively evaluated in terms of preparation, cargo loading, targeting properties, advantages, limitations, and translational potential. Finally, we discuss key challenges in the development and clinical translation of neutrophil‐based therapies, including manufacturing, quality control, safety, and therapeutic precision, and highlight future opportunities for their clinical application.
Related
- Special Issue: Molecular Therapeutic Strategies in Allergic Diseases
- Macrophage reprogramming in degenerative musculoskeletal diseases: From tissue-niche biology to therapeutic translation
- Emerging Therapeutic Strategies for Neurodegenerative Diseases: A Comprehensive Review of Recent Advances and Future Directions
- Insights into the therapeutic strategies for aging and aging-associated diseases
- Extending digital biology: Bacterial survival and morphological heterogeneity under antibiotic stress
BibTeX
@article{zhang2026neutrophils,
title = {{Neutrophils: Heterogeneity, Biology, Diseases, and Therapeutic Strategies}},
author = {Yibing Zhang and Siwen Wu and Yusi Wang and Die Hu and Li Yang},
journal = {MedComm},
year = {2026},
month = oct,
doi = {10.1002/mco2.71104},
url = {https://europepmc.org/article/PMC/PMC13722946},
note = {CC BY},
}
RIS
TY - JOUR
TI - Neutrophils: Heterogeneity, Biology, Diseases, and Therapeutic Strategies
AU - Yibing Zhang
AU - Siwen Wu
AU - Yusi Wang
AU - Die Hu
AU - Li Yang
PY - 2026
DA - 2026/10/31
JO - MedComm
DO - 10.1002/mco2.71104
UR - https://europepmc.org/article/PMC/PMC13722946
AB - Neutrophils are the most abundant circulating leukocytes and are essential components of innate immunity, contributing to host defense, inflammation, tissue remodeling, and disease progression. Increasing evidence has revealed substantial neutrophil heterogeneity and functional plasticity, which enable distinct neutrophil populations to exert protective or pathogenic effects depending on the tissue and disease context. These properties have attracted growing interest in neutrophils as therapeutic targets and as vehicles for targeted drug delivery. This review summarizes the biological characteristics and functional heterogeneity of neutrophils, with particular emphasis on their recruitment, phagocytosis, oxidative responses, extracellular trap formation, and interactions with the tissue microenvironment. We further discuss the diverse roles of neutrophils in cancer, inflammatory diseases, infectious diseases, and other pathological conditions, highlighting their context‐dependent functions. Building on these insights, we review current and emerging therapeutic strategies, ranging from broad neutrophil modulation to precision targeting and neutrophil‐based drug delivery. Living neutrophil carriers, neutrophil membrane‐coated nanoparticles, and neutrophil‐derived vesicles are comparatively evaluated in terms of preparation, cargo loading, targeting properties, advantages, limitations, and translational potential. Finally, we discuss key challenges in the development and clinical translation of neutrophil‐based therapies, including manufacturing, quality control, safety, and therapeutic precision, and highlight future opportunities for their clinical application.
SN - 2688-2663
ER -